[Do Norwegian cancer patients receive the care they deserve?].
Wilking
Nils
N
Karolinska Institutet, Stockholm. nils.vilking@karolinska.se
Jönsson
Bengt
B
Svedman
Christer
C
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004363:Drug Utilization / Q000592:standards*; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000188:drug therapy*; D009664:Norway; D011785:Quality Assurance, Health Care
D000970:Antineoplastic Agents